TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug.
A lot of people are sick in the United States.
( z1 sick :ARG1 ( z2 person :quant ( z3 lot ) ) :location ( z4 country :name ( z5 name :op "United" :op "States" ) ) )